Fondazione Istituto di Ricerca Pediatrica Città della Speranza, Corso Stati Uniti 4, 35129 Padova, Italy; Department of Women and Children Health, University of Padova, Via Giustiniani 2, 35127 Padova, Italy.
Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padova, Via Giustiniani 2, 35127 Padova, Italy.
Acta Biomater. 2019 Apr 15;89:115-125. doi: 10.1016/j.actbio.2019.03.007. Epub 2019 Mar 6.
Congenital diaphragmatic hernia (CDH) is a neonatal defect in which the diaphragm muscle does not develop properly, thereby raising abdominal organs into the thoracic cavity and impeding lung development and function. Large diaphragmatic defects require correction with prosthetic patches to close the malformation. This treatment leads to a consequent generation of unwelcomed mechanical stress in the repaired diaphragm and hernia recurrences, thereby resulting in high morbidity and significant mortality rates. We proposed a specific diaphragm-derived extracellular matrix (ECM) as a scaffold for the treatment of CDH. To address this strategy, we developed a new surgical CDH mouse model to test the ability of our tissue-specific patch to regenerate damaged diaphragms. Implantation of decellularized diaphragmatic ECM-derived patches demonstrated absence of rejection or hernia recurrence, in contrast to the performance of a commercially available synthetic material. Diaphragm-derived ECM was able to promote the generation of new blood vessels, boost long-term muscle regeneration, and recover host diaphragmatic function. In addition, using a GFP + Schwann cell mouse model, we identified re-innervation of implanted patches. These results demonstrated for the first time that implantation of a tissue-specific biologic scaffold is able to promote a regenerating diaphragm muscle and overcome issues commonly related to the standard use of prosthetic materials. STATEMENT OF SIGNIFICANCE: Large diaphragmatic hernia in paediatric patients require application of artificial patches to close the congenital defect. The use of a muscle-specific decellularized scaffold in substitution of currently used synthetic materials allows new blood vessel growth and nerve regeneration inside the patch, supporting new muscle tissue formation. Furthermore, the presence of a tissue-specific scaffold guaranteed long-term muscle regeneration, improving diaphragm performance to almost complete functional recovery. We believe that diaphragm-derived scaffold will be key player in future pre-clinical studies on large animal models.
先天性膈疝 (CDH) 是一种新生儿缺陷,膈肌肌肉发育不正常,导致腹部器官进入胸腔,阻碍肺的发育和功能。大的膈疝缺陷需要用假体补丁来纠正,以关闭畸形。这种治疗方法会导致修复后的膈肌产生不必要的机械应力和疝复发,从而导致高发病率和高死亡率。我们提出了一种特定的膈肌衍生细胞外基质 (ECM) 作为治疗 CDH 的支架。为了实现这一策略,我们开发了一种新的先天性膈疝小鼠模型,以测试我们组织特异性补丁修复受损膈肌的能力。植入脱细胞膈肌 ECM 衍生补丁表明不存在排斥反应或疝复发,而商业上可获得的合成材料则表现不佳。膈肌衍生 ECM 能够促进新血管生成,促进长期肌肉再生,并恢复宿主膈肌功能。此外,使用 GFP+施万细胞小鼠模型,我们鉴定了植入补丁的神经再支配。这些结果首次表明,植入组织特异性生物支架能够促进再生的膈肌肌肉,并克服与标准使用假体材料相关的常见问题。 意义声明:儿科患者的大膈疝需要应用人工补丁来关闭先天性缺陷。用肌肉特异性脱细胞支架替代目前使用的合成材料允许在补丁内新血管生长和神经再生,支持新的肌肉组织形成。此外,组织特异性支架的存在保证了长期的肌肉再生,使膈肌的性能几乎完全恢复到正常功能。我们相信,膈肌衍生支架将成为未来大动物模型的临床前研究的关键参与者。